Company Search:
Advanced Search
Sponsored Links
AngioLab Inc Company Snapshot
AngioLab Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares AngioLab Inc with three other pharmaceutical manufacturers in Asia: Colinz Laboratories Ltd of INDIA (2020 sales of 76.03 million Indian Rupees [US$1.04 million] ), Delta-Fly Pharma Inc of JAPAN (100.00 million Japanese Yen [US$908,000.00 ] of which 100% was Pharmaceutical business), and Ix Biopharma Ltd which is based in SINGAPORE (985,000.00 Singapore Dollars [US$742,276.30 ] of which 61% was Specialty Pharmaceutical).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
AngioLab Inc
  Stock Performance Chart for AngioLab Inc
  Stock Data: Recent Stock Performance:
  Current Price (6/11/2021): 11,000
(Figures in Korean Won )
1 Week 0.9%   13 Weeks -9.8%  
4 Weeks -21.4%   52 Weeks -42.0%  
AngioLab Inc Key Data:
  Ticker: 251280 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 315,545,180
(Year Ending Jan 2021).
Employees: 18
  Currency: Korean Won Market Cap: 24,753,960,000
  Fiscal Yr Ends: December Shares Outstanding: 2,250,360
  Share Type: COMMON Closely Held Shares: 1,219,454
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.